182 related articles for article (PubMed ID: 12165091)
1. Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.
Kaser A; Novick D; Rubinstein M; Siegmund B; Enrich B; Koch RO; Vogel W; Kim SH; Dinarello CA; Tilg H
Clin Exp Immunol; 2002 Aug; 129(2):332-8. PubMed ID: 12165091
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054
[TBL] [Abstract][Full Text] [Related]
3. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
[TBL] [Abstract][Full Text] [Related]
4. Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy.
Zhang L; Hao CQ; Miao L; Dou XG
Genet Mol Res; 2014 Nov; 13(4):9747-55. PubMed ID: 25501184
[TBL] [Abstract][Full Text] [Related]
5. IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice.
Faggioni R; Cattley RC; Guo J; Flores S; Brown H; Qi M; Yin S; Hill D; Scully S; Chen C; Brankow D; Lewis J; Baikalov C; Yamane H; Meng T; Martin F; Hu S; Boone T; Senaldi G
J Immunol; 2001 Nov; 167(10):5913-20. PubMed ID: 11698468
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.
Martinez D; Palmer C; Simar D; Cameron BA; Nguyen N; Aggarwal V; Lloyd AR; Zekry A
Liver Int; 2015 Feb; 35(2):463-72. PubMed ID: 24461080
[TBL] [Abstract][Full Text] [Related]
7. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
[TBL] [Abstract][Full Text] [Related]
9. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo.
Sharara AI; Perkins DJ; Misukonis MA; Chan SU; Dominitz JA; Weinberg JB
J Exp Med; 1997 Nov; 186(9):1495-502. PubMed ID: 9348307
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of IL-18 by interferon alpha-2b/ribavirin combination therapy induces an anti-viral effect in patients with chronic hepatitis C.
Murata K; Yamamoto N; Kawakita T; Saito Y; Yamanaka Y; Sugimoto K; Shiraki K; Nakano T; Tameda Y
Hepatogastroenterology; 2005; 52(62):547-51. PubMed ID: 15816475
[TBL] [Abstract][Full Text] [Related]
11. Clinical observation of serum IL-18, IL-10 and sIL-2R levels in patients with chronic hepatitis C pre- and post antiviral treatment.
Jia H; Du J; Zhu S; Ma Y; Cai H
Chin Med J (Engl); 2003 Apr; 116(4):605-8. PubMed ID: 12875732
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 18 and interleukin 18 binding protein: possible role in immunosuppression of chronic renal failure.
Dinarello CA; Novick D; Rubinstein M; Lonnemann G
Blood Purif; 2003; 21(3):258-70. PubMed ID: 12784053
[TBL] [Abstract][Full Text] [Related]
13. Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis.
Kawashima M; Novick D; Rubinstein M; Miossec P
Arthritis Rheum; 2004 Jun; 50(6):1800-5. PubMed ID: 15188356
[TBL] [Abstract][Full Text] [Related]
14. The combination of soluble IL-18Ralpha and IL-18Rbeta chains inhibits IL-18-induced IFN-gamma.
Reznikov LL; Kim SH; Zhou L; Bufler P; Goncharov I; Tsang M; Dinarello CA
J Interferon Cytokine Res; 2002 May; 22(5):593-601. PubMed ID: 12060498
[TBL] [Abstract][Full Text] [Related]
15. IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease.
Corbaz A; ten Hove T; Herren S; Graber P; Schwartsburd B; Belzer I; Harrison J; Plitz T; Kosco-Vilbois MH; Kim SH; Dinarello CA; Novick D; van Deventer S; Chvatchko Y
J Immunol; 2002 Apr; 168(7):3608-16. PubMed ID: 11907126
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants.
Zecchina G; Novick D; Rubinstein M; Barak V; Dinarello C; Nagler A
J Hematother Stem Cell Res; 2001 Dec; 10(6):769-76. PubMed ID: 11798503
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin.
Marín-Serrano E; Rodríguez-Ramos C; Díaz F; Martín-Herrera L; Girón-González JA
J Viral Hepat; 2006 Apr; 13(4):230-4. PubMed ID: 16611188
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.
Meng P; Zhao S; Niu X; Fu N; Su S; Wang R; Zhang Y; Qiao L; Nan Y
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428948
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.
Ludwiczek O; Kaser A; Novick D; Dinarello CA; Rubinstein M; Vogel W; Tilg H
J Clin Immunol; 2002 Nov; 22(6):331-7. PubMed ID: 12462332
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication.
Iannello A; Boulassel MR; Samarani S; Tremblay C; Toma E; Routy JP; Ahmad A
J Infect Dis; 2010 Feb; 201(4):608-17. PubMed ID: 20078197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
